Biblio
Export 1356 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is P [Clear All Filters]
“Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.”, J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.
, “Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.”, J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.
, “Digital Technologies to Prevent Social Isolation and Loneliness in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 90, no. 2, pp. 513-528, 2022.
, “Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
, “Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 90, no. 1, pp. 119-137, 2022.
, “Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1553-1566, 2022.
, “HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24.”, J Alzheimers Dis, vol. 91, no. 1, pp. 407-426, 2022.
, “Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort.”, J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
, “Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort.”, J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
, “Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1451-1460, 2022.
, “An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins in a Human in vitro Model.”, J Alzheimers Dis, vol. 86, no. 1, pp. 343-364, 2022.
, “Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1073-1080, 2022.
, “Longitudinal Changes in Resting-State Functional Connectivity and Gray Matter Volume Are Associated with Conversion to Hearing Impairment in Older Adults.”, J Alzheimers Dis, vol. 86, no. 2, pp. 905-918, 2022.
, “Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.”, J Alzheimers Dis, vol. 86, no. 1, pp. 491-498, 2022.
, “Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1745-1750, 2022.
, “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
, “A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.”, J Alzheimers Dis, vol. 89, no. 3, pp. 913-922, 2022.
, “Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1727-1744, 2022.
, “Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1493-150, 2022.
, “Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.”, J Alzheimers Dis, vol. 88, no. 1, pp. 335-344, 2022.
, “Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
, “Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 1, pp. 51-66, 2022.
, “Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project.”, J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
, “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
, “Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
,